Enhancement of surface ligand display on PLGA nanoparticles with amphiphilic ligand conjugates
about
Towards Targeted Delivery Systems: Ligand Conjugation Strategies for mRNA Nanoparticle Tumor VaccinesMaterials based tumor immunotherapy vaccinesStrategies to target tumors using nanodelivery systems based on biodegradable polymers, aspects of intellectual property, and marketDetecting and destroying cancer cells in more than one way with noble metals and different confinement properties on the nanoscaleBiodegradable double nanocapsule as a novel multifunctional carrier for drug delivery and cell imagingExploiting the tumor phenotype using biodegradable submicron carriers of chemotherapeutic drugs.Size matters: gold nanoparticles in targeted cancer drug delivery.Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.Targeting human dendritic cells via DEC-205 using PLGA nanoparticles leads to enhanced cross-presentation of a melanoma-associated antigenRadiolabeling of poly(lactic-co-glycolic acid) (PLGA) nanoparticles with biotinylated F-18 prosthetic groups and imaging of their delivery to the brain with positron emission tomography.An artificial antigen-presenting cell with paracrine delivery of IL-2 impacts the magnitude and direction of the T cell response.Cell penetrating peptide-modified poly(lactic-co-glycolic acid) nanoparticles with enhanced cell internalization.Covalent modification of pericardial patches for sustained rapamycin delivery inhibits venous neointimal hyperplasiaDesign, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery.Anti-angiogenic nanotherapy via active targeting systems to tumors and adipose tissue vasculature.Targeted nanotechnologies for cancer intervention: a patent review (2010-2016).Paracrine co-delivery of TGF-β and IL-2 using CD4-targeted nanoparticles for induction and maintenance of regulatory T cells.Surface functionalization of polymeric nanoparticles for tumor drug delivery: approaches and challenges.Development of sulfadiazine-decorated PLGA nanoparticles loaded with 5-fluorouracil and cell viability.Antibody conjugated PLGA nanoparticles for targeted delivery of paclitaxel palmitate: efficacy and biofate in a lung cancer mouse model.Artificial bacterial biomimetic nanoparticles synergize pathogen-associated molecular patterns for vaccine efficacy.Myelin repair in vivo is increased by targeting oligodendrocyte precursor cells with nanoparticles encapsulating leukaemia inhibitory factor (LIF)Homing in on an intracellular target for delivery of loaded nanoparticles functionalized with a histone deacetylase inhibitor.Induced clustered nanoconfinement of superparamagnetic iron oxide in biodegradable nanoparticles enhances transverse relaxivity for targeted theranostics.Surface modification of PLGA nanoparticles via human serum albumin conjugation for controlled delivery of docetaxel.An integrated experimental and modeling approach to propose biotinylated PLGA microparticles as versatile targeting vehicles for drug delivery.Recent Advances in the Generation of Antibody-Nanomaterial Conjugates.iRGD-functionalized PEGylated nanoparticles for enhanced colon tumor accumulation and targeted drug delivery.Functionalizing PLGA and PLGA Derivatives for Drug Delivery and Tissue Regeneration Applications.Targeted Therapeutic Nanoparticles: An Immense Promise to Fight against Cancer.Nanoscale artificial antigen presenting cells for cancer immunotherapy.A carbon nanotube-polymer composite for T-cell therapy.Herceptin conjugated PCL-PEG-PCL triblock copolymer for cancer targeting and imaging
P2860
Q26773073-06EEBCCC-D291-431D-BB0A-A59FBB4B35A5Q26824135-59E0FD1D-BFB6-4A21-942D-BEE558AE9080Q27015050-FF13AFD8-4FE6-4E12-9C1D-D46B4AF2D070Q27339930-CF3E56E0-F009-4F10-8044-60589A480874Q28397490-1F0F3272-182A-459B-A25D-33136071FAF2Q34284213-B7C0F772-616C-4BD2-964F-CD039B95FF4EQ34290392-54613875-A3AA-4756-B9A5-94E59269DE5CQ34447986-F5057CD9-27C7-4EEE-BC6D-A883AC32CF4EQ34532116-15DA006A-2760-4DDD-86C3-8BE0542EE6FCQ34764435-85363587-04A9-430D-A773-46B5C532026FQ35266959-245B195A-9743-41FC-BE82-1DF99C608B4EQ36414890-20544BE4-B879-40B2-8727-07B62FE9F569Q37575912-9E693466-7FA5-44D5-B9DC-7E8BB3199A3CQ38067265-761C94F4-6487-43E4-A5CE-1D6B6D2B4F64Q38564219-30029413-DBCC-49F4-B2B3-7EB40423E067Q38670236-7B984ABC-B623-45BB-9082-84F9FBEEE190Q38874906-0EFBBB22-6A15-4D28-9066-5A9B6922F629Q38899902-C680F8F8-F8A8-4379-8394-C032E3EF2E83Q38920845-19AF8E28-C787-4A98-8122-FFB8F8BDFAA2Q39122521-CFD93756-764B-4130-AC1F-E237271FE7B2Q39780595-96CA88FC-D230-417F-8A78-7FF56B52EE5FQ40617937-6163EE48-7718-4B00-8323-C0AA0D247CA2Q42366612-4941A4F4-12E6-4A87-A53B-41341BADBBA6Q42877109-544B089F-7347-4383-8277-6353C224761EQ43078456-000C14A8-3BA1-4567-93DE-1DD61BF582ADQ46771378-7EA07BFA-F783-4985-A70B-E0F84D317CEFQ47725919-76903EBF-5FD9-4F1B-9CFD-B45BC219FD2DQ47815925-236776D2-9E6C-4960-B86B-AB8F57CD5FF3Q48240255-09F765E8-56B7-40A2-8C91-DF722C8D4C3CQ49787181-DFD71EB7-0C05-4784-83D5-BE744F10FB0EQ52662884-DDA98138-EAB1-4003-B13D-2FA92F2AA443Q53482969-21DD24BC-FC1B-4D28-8094-02A6F76197A8Q57933636-70A68728-315F-4E5B-B86C-02C79DFAB7B3
P2860
Enhancement of surface ligand display on PLGA nanoparticles with amphiphilic ligand conjugates
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Enhancement of surface ligand ...... amphiphilic ligand conjugates
@en
Enhancement of surface ligand ...... amphiphilic ligand conjugates.
@nl
type
label
Enhancement of surface ligand ...... amphiphilic ligand conjugates
@en
Enhancement of surface ligand ...... amphiphilic ligand conjugates.
@nl
prefLabel
Enhancement of surface ligand ...... amphiphilic ligand conjugates
@en
Enhancement of surface ligand ...... amphiphilic ligand conjugates.
@nl
P2093
P2860
P1476
Enhancement of surface ligand ...... amphiphilic ligand conjugates
@en
P2093
Jason Park
Steven M Jay
Tarek M Fahmy
Thomas Mattessich
W Mark Saltzman
P2860
P304
P356
10.1016/J.JCONREL.2011.06.025
P407
P577
2011-06-24T00:00:00Z